Acumen Pharmaceuticals, Inc. (ABOS) DCF Valuation

Acumen Pharmaceuticals, Inc. (ABOS) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Acumen Pharmaceuticals, Inc. (ABOS) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Gain insight into your Acumen Pharmaceuticals, Inc. (ABOS) valuation analysis using our sophisticated DCF Calculator! Preloaded with real (ABOS) data, this Excel template enables you to adjust forecasts and assumptions to accurately determine the intrinsic value of Acumen Pharmaceuticals, Inc. (ABOS).


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 1.7 1.4 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 -15.38 -100 0 0 -28.85 -28.85 -28.85 -28.85 -28.85
EBITDA .1 .6 61.6 -42.7 -51.6 .0 .0 .0 .0 .0
EBITDA, % 7.01 40.88 100 100 100 69.58 69.58 69.58 69.58 69.58
Depreciation 7.8 7.9 .0 .2 .2 .0 .0 .0 .0 .0
Depreciation, % 459.93 550.97 100 100 100 100 100 100 100 100
EBIT -7.7 -7.3 61.6 -42.9 -51.8 .0 .0 .0 .0 .0
EBIT, % -452.92 -510.1 100 100 100 20 20 20 20 20
Total Cash 6.6 43.8 194.2 177.6 243.5 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .1 .0 .0 .2
Account Receivables, % 1.77 7.59 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 0 0 100 100 100 60 60 60 60 60
Accounts Payable .2 .5 1.1 1.6 1.4 .0 .0 .0 .0 .0
Accounts Payable, % 13.14 36.98 100 100 100 70.02 70.02 70.02 70.02 70.02
Capital Expenditure .0 .0 .0 -.2 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 0 0 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -7.6 -7.3 111.2 -40.5 -51.8 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF .4 .8 111.8 -39.9 -52.1 -1.2 .0 .0 .0 .0
WACC, % 5.15 5.16 5.16 5.1 5.16 5.15 5.15 5.15 5.15 5.15
PV UFCF
SUM PV UFCF -1.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -1
Net Debt -38
Equity Value 37
Diluted Shares Outstanding, MM 49
Equity Value Per Share 0.77

What You Will Receive

  • Customizable Excel Template: A fully adjustable Excel-based DCF Calculator featuring pre-filled real Acumen Pharmaceuticals (ABOS) financials.
  • Authentic Data: Historical data and projected estimates (highlighted in the yellow cells).
  • Flexible Forecasting: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Instant Calculations: Quickly observe the effects of your inputs on Acumen Pharmaceuticals' valuation.
  • Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
  • Intuitive Design: Organized for clarity and user-friendliness, complete with step-by-step guidance.

Key Features

  • Customizable Research Parameters: Adjust key factors such as clinical trial timelines, revenue forecasts, and research expenditures.
  • Instant Valuation Metrics: Provides real-time calculations for intrinsic value, NPV, and additional financial outputs.
  • High-Precision Analysis: Leverages Acumen Pharmaceuticals’ (ABOS) actual financial data for accurate valuation results.
  • Effortless Scenario Testing: Easily evaluate various assumptions and analyze different outcomes.
  • Efficiency Booster: Streamlines the valuation process, eliminating the need for complex model construction from the ground up.

How It Works

  • Step 1: Download the prebuilt Excel template with Acumen Pharmaceuticals' data included.
  • Step 2: Explore the pre-filled sheets and familiarize yourself with the key metrics.
  • Step 3: Update forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly view recalculated results, including Acumen Pharmaceuticals' intrinsic value.
  • Step 5: Make informed investment decisions or generate reports using the outputs.

Why Choose This Calculator for Acumen Pharmaceuticals, Inc. (ABOS)?

  • Accurate Data: Leverage real Acumen Pharmaceuticals financials for dependable valuation outcomes.
  • Customizable: Tailor essential parameters like growth rates, WACC, and tax rates to fit your forecasts.
  • Time-Saving: Utilize pre-built calculations to avoid starting from scratch.
  • Professional-Grade Tool: Crafted for investors, analysts, and consultants in the pharmaceutical sector.
  • User-Friendly: Easy-to-navigate layout and clear instructions ensure accessibility for all users.

Who Should Use This Product?

  • Investors: Gain a precise understanding of Acumen Pharmaceuticals’ fair value prior to making investment choices.
  • CFOs: Utilize a professional-grade DCF model for comprehensive financial reporting and analysis.
  • Consultants: Efficiently customize the template for client valuation reports.
  • Entrepreneurs: Discover insights into financial modeling practices employed by leading pharmaceutical companies.
  • Educators: Employ it as a teaching resource to illustrate valuation techniques.

What the Template Contains

  • Preloaded ABOS Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.